Moteur de recherche d’entreprises européennes
Financement de l’UE (9 987 744 €) : Infrastructure pour l’accès transnational et la découverte en biologie structurale Hor24/01/2020 Programme de recherche et d'innovation de l'UE « Horizon »
Vue d’ensemble
Texte
Infrastructure pour l’accès transnational et la découverte en biologie structurale
Structural biology reveals the molecular architecture of life; the three-dimensional structure of biomolecules and how they interact to form complex machineries and ?????. Structural biology is key to innovations in chemistry, biotechnology and medicine: new drugs, advanced vaccines, novel biomaterials, engineered enzymes for food production, a cleaner environment, and efficient biofuels. iNEXT-Discovery takes on the challenge of proactively supporting the uptake of existing tools, and the innovation of new tools, to promote scientific Discovery and translation in a range of disciplines, building on the success of the H2020 project iNEXT (infrastructure for NMR, EM and X-rays for Translational research). iNEXT-Discovery brings together a strong network of leading structural biology facilities in partnership with regional experts and ESFRI communities in medicinal chemistry, translational medicine, biological imaging, and food research, to disseminate knowledge and services. We aim to stimulate the wider uptake of structural biology across Europe, across scientific disciplines and research sectors. Significant hardware and software advances allow targeting transnational access to advanced instrumentation also to scientists without previous expertise in structural biology: uptake will be facilitated by training and thematic calls focused on new communities. Access to our instrumentation and expertise will ultimately allow European scientists to gain structural insight that can translate into innovations in the biomedical, food, biotechnological and biomaterials sectors. Our joint research activities will roll-out advances in key technologies for translational research: fragment screening for drug development, EM efficiency and capacity, NMR applications to extend structures beyond three dimensions, and integrative structural biology approaches to look at macromolecules in ?????. All our activities support innovative research of both academic and industrial users.
| Aarhus Universitet | 129 500 € |
| Agencia Estatal Consejo Superior de Investigaciones Cientificas | 480 308 € |
| 24 375 € | |
| Centre Europeen de Recherche en Biologie et Medecine | 435 813 € |
| Centre National de la Recherche Scientifique Cnrs | 371 255 € |
| Commissariat a L Energie Atomique et aux Energies Alternatives | 0,00 € |
| 310 888 € | |
| 719 740 € | |
| Diamond Light Source Ltd. | 921 000 € |
| 24 375 € | |
| 1 895 231 € | |
| 19 375,00 € | |
| 59 375 € | |
| 18 125,00 € | |
| HELMHOLTZ-ZENTRUM BERLIN für MATERIALIEN UND ENERGIE GmbH | 432 375 € |
| 147 500 € | |
| JOHANN WOLFGANG GOETHE-UNIVERSITAET FRANKFURT AM MAIN | 761 406 € |
| Lunds Universitet | 196 685 € |
| Masarykova Univerzita | 656 546 € |
| Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej w Warszawie | 59 375 € |
| Stichting HET Nederlands Kanker Instituut-Antoni Van Leeuwenhoek Ziekenhuis | 1 122 375 € |
| Synchrotron Soleil Societe Civile | 168 667 € |
| 21 875 € | |
| Universita Degli Studi DI Firenze | 0,00 € |
| Universiteit Leiden | 168 358 € |
| Universiteit Utrecht | 696 300 € |
| University of Leeds | 128 797 € |
| 18 125,00 € |
https://cordis.europa.eu/project/id/871037
Cette annonce se réfère à une date antérieure et ne reflète pas nécessairement l’état actuel.
Les visualisations de "Aarhus Universitet - Financement de l’UE (9 987 744 €) : Infrastructure pour l’accès transnational et la découverte en biologie structurale"
sont mis à disposition par
North Data
et peuvent être réutilisées selon les termes de la licence
Creative Commons CC-BY.
